RONALD BROWN: Open Payments
NPI 1477191237 · GUNTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 36 payments from 23 companies in 2025. Trend: 2023 $489 · 2024 $1,193 · 2025 $939
Food & beverage: $781Education: $158
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $170 |
| AstraZeneca Pharmaceuticals LP | 3 | $91 |
| Astellas Pharma US Inc | 1 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Eisai Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| SpringWorks Therapeutics, Inc. | 1 | $29 |
Products named: ERLEADA, KISQALI, Lenvima, Nubeqa, XTANDI, TALVEY, OGSIVEO, ENHERTU.
Industry payments across TX — which companies pay providers there.
